MarketInOut Stock Screener Log In | Sign Up

Dogwood Therapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Dogwood Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization43.51 mln
Float8.81 mln
Earnings Date11/05/2026

EPS

2.20
Solid

P / E

0.58
Anomalous

Piotroski F-Score

3 / 9
Below average

Relative Strength

85 / 100
Strongly outperforming

Debt / Equity

0.00
Debt-free

ROE

-46.95
Deeply negative

Business Description

Dogwood Therapeutics Inc., formerly Virios Therapeutics, is a Georgia-based company founded in 2012 that develops treatments for pain and fatigue conditions. Its pipeline includes several drug candidates at various stages of testing, covering fibromyalgia, nerve pain caused by chemotherapy, cancer pain, and herpesvirus-related conditions. The company's approach often involves combining existing medications to achieve stronger therapeutic effects.

Key Fundamentals

EPS2.20
P/E0.58
ROE-46.95
ROIC-34.59
ROA-39.60
EBITDA, mln-38.42
EV / EBITDA-0.80
EV / EBIT-0.80

Quote Details

Last 1.28
Change 0.05 (4.07%)
Open 1.30
Volume 57,686
Turnover 73,838
Average Volume 73,731

Financial Ratios

Leverage Ratio1.18
Current Ratio3.89
Price / Book0.57
Debt / Equity0.00

Financial Strength

Piotroski F-Score 3 / 9
Short Ratio0.90
Short % of Float0.51

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 14.29% 96 / 100   
1 Month -10.49% 28 / 100   
2 Months -16.34% 25 / 100   
6 Months -12.33% 32 / 100   
1 Year -79.25% 9 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog